Vol 204 - N° 1 - janvier 2020
P. 1-114© Académie nationale de Médecine
Page :i
Joseph Babinski, the man behind a sign
Page :1-3
J. Cambier
Use of licit and illicit drugs in teenagers: An alarming situation, which requires early prevention
Page :4-15
J.-P. Goullé, F. Morel, Sous commission addictions rattachée à la Commission V Santé mentale neurosciences addictions
Major progress in vasculitis
Page :16-17
L. Guillevin
Giant cell arteritis: From pathogenesis to new therapeutic targets
Page :18-28
M. Samson, H. Greigert, T. Ghesquiere, B. Bonnotte
Takayasu arteritis therapy: The role of imaging in the exploration of the disease and its interventional results
Page :29-40
T. Mirault
Eosinophilic granulomatosis with polyangiitis: Pathogenesis and therapeutic consequences
Page :41-47
B. Terrier
Maintenance treatment for antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides
Page :48-52
L. Guillevin
Discussion about the presentation: “Giant Cell Arteritis: from pathogenesis to new therapeutic targets”
Page :53-57
M. Samson
Discussion about the presentation: “Takayasu arteritis therapy: the role of imaging in the exploration of the disease and its interventional results”
Page :58
T. Mirault
Discussion about the presentation: “Maintenance treatment for antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides”
Page :59
L. Guillevin
Optimisation of classic treatments and new therapeutic perspectives in Parkinson's disease
Page :60-65
J.-C. Corvol
Parkinson's disease is also a gastrointestinal tract disorder
Page :66-71
P. Derkinderen
An update about gait disorders and its management in Parkinson's disease
Page :72-76
C. Moreau
Discussion about the presentation: “Parkinson's disease is also a gastrointestinal tract disorder”
Page :77-78
P. Derkinderen
Assessment of individual or collective therapeutic education for patients with cardiovascular risk: ETHICCAR study
Page :79-86
B. Gay, J.-L. Demeaux, M. Afonso
How genes redesign the enlarging field of endocrine tumors
Page :87-96
X. Bertagna
The model of anaphylaxis: A new version of the International Classification of Diseases from the World Health Organization
Page :97-101
P. Demoly, L. Kase Tanno
Carotid revascularization in patients with asymptomatic carotid stenosis?
Page :102-108
J.-L. Mas
Discussion about the presentation: “Assessement of individual or collective therapeutic education for patients with cardiovascular risk: ETHICCAR study”
Page :109-110
B. Gay
Discussion about the presentation: “The model of anaphylaxis: A new version of the International Classification of Diseases from the World Health Organization”
Page :111-112
P. Demoly
Page :113
D. Bertrand
EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.
En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.